Announcement of CE-mark for new product: Breast HER2 RoI
We are very proud to announce the CE-mark for another new product: Mindpeak Breast HER2 RoI (Region of Interest) supports pathologists in the scoring of digital images of breast cancer tissue, which underwent immunohistochemical (IHC) staining of the human epidermal growth factor receptor 2 (HER2). The statistical evaluation shows that the agreement rate of nearly 79% when scoring assisted by Mindpeak Breast HER2 RoI is significantly larger than the clinical state-of-the-art agreement rate of 68% when scoring manually. Breast HER2 RoI is the 8th CE-marked product we have launched into the market in the last 14 months.
Find out more about our AI-based diagnostics
Company information
Local court Hamburg HRB 151143
Managing director:
Felix Faber
V.A.T. identification number:
DE318495606
Founded in 2018
.webp)
© 2024 Mindpeak GmbH
Supported by:
